One of the strengths of our study is that we included a sufficient amount of 45 psoriasis and PsA patients and 17 healthy controls, all sex and age-matched, to provide insight in the distribution of CCR6+ Th subpopulations among psoriasis and PsA patients. Here, CCR6 is linked to psoriasis.